Eurofins CDMO Alphora.
| Publicado en: | Pharmaceutical Technology Vol. 48; pp. 28 - 29 |
|---|---|
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Dec2024Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181258222&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 181258222 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Dec2024Supplement vid: 48 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 181258222 181258222 ppf: 28 ppct: 1 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Eurofins CDMO Alphora. aug: sug: subj: Manufacturing Industry Canada Pharmaceutical Companies Drug Development Antibodies, Monoclonal Contract Services Canada Chemistry, Pharmaceutical Cannabinoids Proteins Drug Evaluation, Preclinical Chemistry, Analytical North America Europe pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|